Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Ewing Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01610570
What this trial is testing

Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma

Who this might be right for
Ewing SarcomaSarcoma
National Cancer Institute (NCI) 8
Early research (Phase 1)WithdrawnNCT01969942
What this trial is testing

A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
University of Louisville
Testing effectiveness (Phase 2)Study completedNCT05395741
What this trial is testing

Regorafenib in Patients With Refractory Primary Bone Tumors

Who this might be right for
OsteosarcomaEwing Sarcoma of Bone
Institute of Mother and Child, Warsaw, Poland 30
Early research (Phase 1)Looking for participantsNCT07222735
What this trial is testing

Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

Who this might be right for
SarcomaChildhood OsteosarcomaChildhood Rhabdomyosarcoma+2 more
St. Jude Children's Research Hospital 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Ended earlyNCT04129151
What this trial is testing

Palbociclib + Ganitumab In Ewing Sarcoma

Who this might be right for
Ewing SarcomaEwing's Sarcoma Recurrent
Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)Temporarily pausedNCT04890093
What this trial is testing

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Sarcoma, EwingRhabdomyosarcoma
National Cancer Institute (NCI) 64
Early research (Phase 1)Looking for participantsNCT05210374
What this trial is testing

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Who this might be right for
Relapsed Sarcomas
Case Comprehensive Cancer Center 24
Not applicableStudy completedNCT06202599
What this trial is testing

Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance

Who this might be right for
Bone SarcomaSoft Tissue SarcomaRefractory Tumor
Peking University People's Hospital 124
Testing effectiveness (Phase 2)Study completedNCT03245151
What this trial is testing

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

Who this might be right for
Recurrent and Refractory Solid Tumors
Eisai Inc. 64
Testing effectiveness (Phase 2)Study completedNCT01492673
What this trial is testing

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 9
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT06566092
What this trial is testing

Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants

Who this might be right for
Soft Tissue SarcomaPrimary Central Nervous System CarcinomaMelanoma+2 more
Iovance Biotherapeutics, Inc. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830667
What this trial is testing

CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat

Who this might be right for
Recurrent Childhood Ewing SarcomaRecurrent Childhood Malignant Solid NeoplasmRecurrent Childhood Rhabdomyosarcoma+9 more
Children's Oncology Group 79
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07444918
What this trial is testing

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Who this might be right for
Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma)
Tianjin Medical University Cancer Institute and Hospital 33
Early research (Phase 1)Study completedNCT02085148
What this trial is testing

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Who this might be right for
Pediatric Oncology
Bayer 62
Not applicableStudy completedNCT02162732
What this trial is testing

Molecular-Guided Therapy for Childhood Cancer

Who this might be right for
NeuroblastomaMedulloblastomaGlioma+16 more
Giselle Sholler 186
Testing effectiveness (Phase 2)Study completedNCT01154816
What this trial is testing

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Acute Lymphoblastic Leukemia+8 more
Children's Oncology Group 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT05440786
What this trial is testing

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Who this might be right for
Sarcoma, EwingNeoplasm Metastasis
Eli Lilly and Company 46
Next Page